LucenceINSIGHT™ Cancer Screening
What is LucenceINSIGHT™ Cancer Screening?
At Wonderhealth Screeners, we proudly offer LucenceInsight Screen, a revolutionary multi-cancer early detection (MCED) test that can detect up to 50 types of cancers through a simple, non-invasive blood test.
LucenceINSIGHT™ is a state-of-the-art liquid biopsy test designed to detect cancer by analyzing circulating tumor DNA (ctDNA) in the blood. Unlike traditional cancer screenings that often focus on one or a few specific types of cancer, this innovative test covers a broad spectrum, offering a comprehensive assessment in a single procedure.
Key Features:
Broad Coverage: Detects signals for up to 50 types of cancers, including common ones like breast, lung, and colorectal cancer, as well as rarer cancers.
Non-Invasive: A simple blood draw is all that is required, making the process fast and convenient.
Advanced Technology: Uses next-generation sequencing (NGS) and AI-driven analysis for accurate results.
High Accuracy: Demonstrates high sensitivity and specificity, reducing the risk of false positives or negatives.
How LucenceINSIGHT™ Cancer Screening Works?
Screen up to 50 Cancers
LucenceINSIGHT™ uses advanced liquid biopsy technology to detect genomic changes associated with up to 50 types of cancer, offering broad coverage in a single screening.
1 Blood Draw
The screening process requires only one simple blood draw, making it a convenient and minimally invasive option for those seeking proactive cancer detection.
12-18 Days for Results
Once your blood sample is collected, results are typically available within 12 to 18 days, allowing for timely discussion and follow-up with Wonderhealth.
Benefits of LucenceINSIGHT™ Screening
Early Detection of Multiple Cancers
Identifies cancers in early stages when treatment is most effective.
Minimal Disruption
Non-invasive, quick, and requires no downtime or recovery.
Comprehensive Insights
Covers multiple types of cancer in a single test, unlike conventional screenings that target specific cancers.
Personalized Follow-Up
Test results are reviewed by experienced medical professionals who provide tailored recommendations.
Who Should Consider LucenceINSIGHT™?
LucenceINSIGHT™ is ideal for individuals who:
Have a family history of cancer.
Are at higher risk due to lifestyle factors or environmental exposures.
Seek a proactive approach to health management.
Prefer a non-invasive screening method.
4X Higher Survival with Early Diagnosis
Up to 50 Cancers screened with 1 Blood Draw
78% Of Cancer Deaths are Unscreened
Why Screen for Cancer Early?
What To Expect During Your LucenceINSIGHT™ Screening?
1. Schedule Your Appointment
2. Visit The Clinic
3. Receive And Discuss Your Results
Your results will be ready in approximately 12 to 18 days. Once available, your doctor will walk you through the findings and recommend next steps, if necessary.
LucenceINSIGHT™ Packages
LucenceINSIGHT™ 5
5 Cancer Types- Lung (Small cell lung cancer, Non-small cell lung cancer)
- Colorectal
- Liver
- Pancreatic
- Thyroid
LucenceINSIGHT™ Women’s 7
7 Cancer Types- Lung (Small cell lung cancer, Non-small cell lung cancer)
- Colorectal
- Liver
- Pancreatic
- Thyroid
- Breast
- Ovarian
LucenceINSIGHT™ Women’s 12
12 Cancer Types- Lung (Small cell lung cancer, Non-small cell lung cancer)
- Colorectal
- Liver
- Pancreatic
- Thyroid
- Breast
- Ovarian
- Stomach
- Gastrointestinal stromal tumor (GIST)
- Nasopharyngeal
- Cervical
- Endometrial
LucenceINSIGHT™ Men’s 12
12 Cancer Types- Lung (Small cell lung cancer, Non-small cell lung cancer)
- Colorectal
- Liver
- Pancreatic
- Thyroid
- Bladder
- Prostate
- Stomach
- Gastrointestinal stromal tumor (GIST)
- Nasopharyngeal
- Kidney (Clear cell)
- Esophageal
LucenceINSIGHT™ 50
50 Cancer Types- Lung (Small cell lung cancer, Non-small cell lung cancer)
- Colorectal
- Liver
- Pancreatic
- Thyroid
- Breast
- Ovarian
- Bladder
- Prostate
- Kidney (Clear cell)
- Esophageal
- Stomach
- Gastrointestinal stromal tumor (GIST)
- Cervical
- Endometrial
- Stomach Neuroendocrine Tumors
- Colorectal Neuroendocrine Tumors
- Ovarian Germ cell & Stromal Tumors
- Lung Neuroendocrine Tumors
- Myeloproliferative Neoplasm
- Acute Myeloid Leukemia
- Non-Hodgkin Lymphoma
- Hairy Cell Leukemia
- Adult Wilms Tumor
- Mast Cell Tumor
- Small Intestine
- Adrenal Gland
- Biliary Tract
- Soft Tissue
- Myeloma
- Testicular
- Bone
- Skin
- Eye
- Head
- Neck
- Vulvar
- Penile
Frequently Asked Questions About LucenceINSIGHT™ Cancer Screening
Is The LucenceINSIGHT™ Cancer Screening Approved In Singapore?
Is The LucenceINSIGHT™ Cancer Screening Covered By Insurance?
How Should I Prepare For The Test?
No fasting is needed. Refrain from heavy meals 4 hours before the test.
Why Should You Screen Cancer Early With LucenceINSIGHT™ Cancer Screening?
Who Is Recommended For LucenceINSIGHT™ Cancer Screening?
- Individuals aged 40 and above without personal history of cancer
- Individuals with elevated risk for cancer (eg, family history of cancer, diet, lifestyle etc)
How does LucenceINSIGHT™ Cancer Screening Differ From The Usual Cancer Markers Like CA19-9?
How Often Should I Do LucenceINSIGHT™ Cancer Screening?
How Does LucenceINSIGHT™ Cancer Screening Work?
What Is The Difference Between LucenceINSIGHT™ 12 And LucenceINSIGHT™ 50?
How Long Does It Take To Get The Results?
Results are typically available within 12 to 18 working days after the blood sample is collected.
Can I Take This Test Even If I Have No Symptoms?
Yes, LucenceINSIGHT™ is suitable for individuals who want proactive cancer screening, even in the absence of symptoms.
Important Notes:
LucenceINSIGHT™ screens for signals of cancer. The test does not diagnose cancer. If a positive result is found, further confirmatory diagnostic testing is recommended.
LucenceINSIGHT™ does not predict inherited risk of cancer where it is pre-disposed within the family, such as breast cancer.
LucenceINSIGHT™ is not recommended for individuals who are pregnant, or have a history of cancer in the past 3 years.
This clinical test was developed and its performance characteristics were determined by Lucence Diagnostics Pte Ltd, a company registered in Singapore (Company ID: 201605840N). This test is used for clinical purposes. It should not be regarded as investigational or for research. This laboratory is certified under the Clinical Laboratory Improvement Amendments (CLIA) as qualified to perform high-complexity clinical laboratory testing. Lucence Diagnostics Pte Ltd is licensed by the Ministry of Health (Singapore) as a Clinical Laboratory (License Number: L/17I0039/CLB/003/222) under the Healthcare Services Act 2020.
- International Agency for Research on Cancer (IARC). Global Cancer Observatory. https://gco.iarc.fr/. 2020 Data, Accessed Dec 2022.
- American Cancer Society. https://www.cancer.org/cancer.html
- https://insight.lucence.com/